158 related articles for article (PubMed ID: 35196345)
1. Polypharmacy occurrence and the related risk of premature death among older adults in Denmark: A nationwide register-based cohort study.
Jørring Pallesen AV; Kristiansen M; Westendorp RGJ; Mortensen LH
PLoS One; 2022; 17(2):e0264332. PubMed ID: 35196345
[TBL] [Abstract][Full Text] [Related]
2. Polypharmacy is a risk factor for mortality, severe chronic kidney disease, and liver disease among privately insured adults with cerebral palsy.
Whitney DG; Schmidt M; Haapala H
J Manag Care Spec Pharm; 2021 Jan; 27(1):51-63. PubMed ID: 33377441
[No Abstract] [Full Text] [Related]
3. Cardiovascular Outcomes and Mortality Associated With Discontinuing Statins in Older Patients Receiving Polypharmacy.
Rea F; Biffi A; Ronco R; Franchi M; Cammarota S; Citarella A; Conti V; Filippelli A; Sellitto C; Corrao G
JAMA Netw Open; 2021 Jun; 4(6):e2113186. PubMed ID: 34125221
[TBL] [Abstract][Full Text] [Related]
4. Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005-2017.
Thomsen MK; Løppenthin KB; Bidstrup PE; Andersen EW; Dalton S; Petersen LN; Pappot H; Mortensen CE; Christensen MB; Frølich A; Lassen U; Johansen C
Acta Oncol; 2023 Dec; 62(12):1653-1660. PubMed ID: 37874076
[TBL] [Abstract][Full Text] [Related]
5. Comparison of incidence, predictors, and the impact of co-morbidity and polypharmacy on the risk of recurrent syncope in patients <85 versus ≥85 years of age.
Ruwald MH; Hansen ML; Lamberts M; Hansen CM; Numé AK; Vinther M; Køber L; Torp-Pedersen C; Hansen J; Gislason GH
Am J Cardiol; 2013 Nov; 112(10):1610-5. PubMed ID: 24035171
[TBL] [Abstract][Full Text] [Related]
6. The impact of high-risk medications on mortality risk among older adults with polypharmacy: evidence from the English Longitudinal Study of Ageing.
Huang YT; Steptoe A; Wei L; Zaninotto P
BMC Med; 2021 Dec; 19(1):321. PubMed ID: 34911547
[TBL] [Abstract][Full Text] [Related]
7. High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality.
Woudstra OI; Kuijpers JM; Meijboom FJ; Post MC; Jongbloed MRM; Duijnhouwer AL; van Dijk APJ; van Melle JP; Konings TC; Zwinderman AH; Mulder BJM; Bouma BJ
Eur Heart J Cardiovasc Pharmacother; 2019 Oct; 5(4):216-225. PubMed ID: 30903133
[TBL] [Abstract][Full Text] [Related]
8. Remaining Life Expectancy With and Without Polypharmacy: A Register-Based Study of Swedes Aged 65 Years and Older.
Wastesson JW; Canudas-Romo V; Lindahl-Jacobsen R; Johnell K
J Am Med Dir Assoc; 2016 Jan; 17(1):31-5. PubMed ID: 26341036
[TBL] [Abstract][Full Text] [Related]
9. Patient factors associated with new prescribing of potentially inappropriate medications in multimorbid US older adults using multiple medications.
Jungo KT; Streit S; Lauffenburger JC
BMC Geriatr; 2021 Mar; 21(1):163. PubMed ID: 33676398
[TBL] [Abstract][Full Text] [Related]
10. Polypharmacy and mortality: new insights from a large cohort of older adults by detection of effect modification by multi-morbidity and comprehensive correction of confounding by indication.
Schöttker B; Saum KU; Muhlack DC; Hoppe LK; Holleczek B; Brenner H
Eur J Clin Pharmacol; 2017 Aug; 73(8):1041-1048. PubMed ID: 28540438
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of polypharmacy in older adults: register-based prospective cohort study.
Morin L; Johnell K; Laroche ML; Fastbom J; Wastesson JW
Clin Epidemiol; 2018; 10():289-298. PubMed ID: 29559811
[TBL] [Abstract][Full Text] [Related]
12. Increased all-cause mortality with psychotropic medication in Parkinson's disease and controls: a national register-based study.
Frandsen R; Baandrup L; Kjellberg J; Ibsen R; Jennum P
Parkinsonism Relat Disord; 2014 Nov; 20(11):1124-8. PubMed ID: 25164488
[TBL] [Abstract][Full Text] [Related]
13. Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
Loeppenthin K; Dalton SO; Johansen C; Andersen E; Christensen MB; Pappot H; Petersen LN; Thisted LB; Frølich A; Mortensen CE; Lassen U; Ørsted J; Bidstrup PE
Br J Cancer; 2020 Sep; 123(6):1033-1040. PubMed ID: 32632149
[TBL] [Abstract][Full Text] [Related]
14. Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.
Folkestad L
Dan Med J; 2018 Apr; 65(4):. PubMed ID: 29619932
[TBL] [Abstract][Full Text] [Related]
15. Association of healthy lifestyle and all-cause mortality according to medication burden.
Kelly NA; Soroka O; Onyebeke C; Pinheiro LC; Banerjee S; Safford MM; Goyal P
J Am Geriatr Soc; 2022 Feb; 70(2):415-428. PubMed ID: 34695226
[TBL] [Abstract][Full Text] [Related]
16. The impact of ART on union dissolution: a register-based study in Denmark 1994-2010.
Martins MV; Vassard D; Hougaard CØ; Schmidt L
Hum Reprod; 2018 Mar; 33(3):434-440. PubMed ID: 29370393
[TBL] [Abstract][Full Text] [Related]
17. Association of Polypharmacy with Colorectal Cancer Survival Among Older Patients.
Chen LJ; Nguyen TNM; Chang-Claude J; Hoffmeister M; Brenner H; Schöttker B
Oncologist; 2021 Dec; 26(12):e2170-e2180. PubMed ID: 34476870
[TBL] [Abstract][Full Text] [Related]
18. Influenza vaccination and 1-year risk of myocardial infarction, stroke, heart failure, pneumonia, and mortality among intensive care unit survivors aged 65 years or older: a nationwide population-based cohort study.
Christiansen CF; Thomsen RW; Schmidt M; Pedersen L; Sørensen HT
Intensive Care Med; 2019 Jul; 45(7):957-967. PubMed ID: 31187170
[TBL] [Abstract][Full Text] [Related]
19. Premature Mortality Among Patients Recently Discharged From Their First Inpatient Psychiatric Treatment.
Walter F; Carr MJ; Mok PLH; Astrup A; Antonsen S; Pedersen CB; Shaw J; Webb RT
JAMA Psychiatry; 2017 May; 74(5):485-492. PubMed ID: 28296989
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy status as an indicator of mortality in an elderly population.
Jyrkkä J; Enlund H; Korhonen MJ; Sulkava R; Hartikainen S
Drugs Aging; 2009; 26(12):1039-48. PubMed ID: 19929031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
